Investor Day to be held in New York on March 19 at 9 am. Webcast LinkLight Up your Portfolio with Spark:Easily identify stocks' risks and ...

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

At a meeting with analysts and investors at its 2025 Investor Day, members of the leadership team of Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, will discuss ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, will host an Investor Day for institutional investors and financial analysts in New York City on Thursday ...

Quest Diagnostics adjusts Q1 revenue & EPS outlook due to weather impact, projects 4-5% CAGR revenue growth beyond 2025. Read ...

Quest Diagnostics ... in the day. The main reason for the bullish move wasn't hard to figure out -- Quest posted its fourth-quarter and full-year 2024 results this morning. Investors were ...

Shares of Quest Diagnostics (NYSE: NYSE:DGX) tumbled 4.75% today after the company provided long-term guidance that failed to meet investor expectations. Despite reaffirming its full-year 2025 ...

This was the stock's third consecutive day of losses.

Quest Diagnostics Inc. closed 2.79% short of its 52-week high of $178.09, which the company reached on March 3rd.

Explore Quest Diagnostics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DGX. Grail shares are trading higher Wednesday after the company announced a ...

Below, we take a look at Quest Diagnostics (DGX), which ... respectively. Investors should also take note of DGX's average 20-day trading volume. Volume is a useful item in many ways, and the ...

Quest Diagnostics saw robust growth in earnings ... confidence in the business's core strength and strategic initiatives. Investors should closely monitor Quest's cost management strategies ...